Sección de Cardiología Pediátrica, Unidad de Gestión Clínica de Pediatría, Hospital Universitario Puerta del Mar, Cádiz, España.
Sección de Nefrología Pediátrica, Unidad de Gestión Clínica de Pediatría, Hospital Universitario Puerta del Mar, Cádiz, España.
Emergencias. 2019;31(2):111-114.
The main objective was to assess the diagnostic usefulness of age-adjusted level of N-terminal prohormone of brain natriuretic peptide (NT-proBNP) as a diagnostic marker in children suspected of having incomplete Kawasaki disease (IKD). The secondary aim was to compare the diagnostic yield of NT-proBNP level with the yield of other markers currently recommended by the American Heart Association (AHA).
Descriptive cross-sectional study of a case series of patients under the age of 14 years admitted with clinical suspicion of IKD between 2013 and 2017. We analyzed NT-proBNP level adjusted for age. Demographic, clinical, echocardiographic, analytic, and microbiologic findings were gathered from computerized charts. Two independent evaluators made the diagnosis of IKD according to AHA criteria.
We included 70 cases, and 19 (27%) were diagnosed with IKD. Patients with IKD had higher NT-proBNP levels than patients with other febrile diseases, and the proportion of cases of elevated age-adjusted NT-proBNP level was also higher in the IKD group (84% vs 4%; P<.001). The diagnostic yield of age-adjusted NT-proBNP for IKD was good (area under the receiver operating characteristic curve, 0.90; 95% CI, 0.80-0.99) and significantly higher than the yields for C-reactive protein, erythrocyte sedimentation rate, albumin, and sterile pyuria (P<.001, all comparisons).
NT-proBNP level may prove to be a valid diagnostic marker for IKD, possibly offering a higher diagnostic yield than the analyses currently recommended for children suspected of having IKD.
本研究旨在评估校正年龄后的脑钠肽前体 N 端(NT-proBNP)水平作为不典型川崎病(IKD)患儿的诊断标志物的诊断效能。次要目的是比较 NT-proBNP 水平与美国心脏协会(AHA)目前推荐的其他标志物的诊断效能。
这是一项病例系列的描述性横断面研究,纳入 2013 年至 2017 年间因疑似 IKD 而入院的年龄<14 岁的患者。我们分析了校正年龄后的 NT-proBNP 水平。从电子病历中收集人口统计学、临床、超声心动图、分析和微生物学资料。两名独立评估者根据 AHA 标准做出 IKD 的诊断。
共纳入 70 例患者,其中 19 例(27%)被诊断为 IKD。与其他发热性疾病患者相比,IKD 患者的 NT-proBNP 水平更高,且 IKD 组中校正年龄后的 NT-proBNP 水平升高的病例比例也更高(84%比 4%;P<.001)。校正年龄后的 NT-proBNP 对 IKD 的诊断效能良好(ROC 曲线下面积为 0.90;95%CI:0.80-0.99),且显著高于 C 反应蛋白、红细胞沉降率、白蛋白和无菌性脓尿的诊断效能(均 P<.001,所有比较)。
NT-proBNP 水平可能是 IKD 的有效诊断标志物,其诊断效能可能优于目前推荐用于疑似 IKD 患儿的分析。